For example, miR-101 was shown to regulate cell proliferation and apoptosis by targeting mitogen-activated protein kinase 1 (MEK1), an upstream protein kinase of the ERK/MAPK pathway, in DLBCL [63]. This evidence concerns the gene MAP2K1 and diffuse large B-cell lymphoma.